Anika Therapeutics Inc. · NASDAQ:ANIK
Trigran Investments, Inc. reported a 11.20% stake in Anika Therapeutics Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 7, 2025
Trigran Investments, Inc. reported a 11.20% stake in Anika Therapeutics Inc., 1,621,215 shares, as a passive investor on Sep 30, 2025. Filed Nov 7, 2025 (Schedule 13G/A).
- Stake
- 11.20%
- Shares
- 1,621,215
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trigran Investments, Inc. | 11.20% | 1,621,215 |
| Douglas T. Granat | 11.20% | 1,621,215 |
| Lawrence A. Oberman | 11.20% | 1,621,215 |
| Steven G. Simon | 11.20% | 1,621,215 |
| Bradley F. Simon | 11.20% | 1,621,215 |
| Steven R. Monieson | 11.20% | 1,621,215 |
Source
Related
- Anika Therapeutics Inc.
- Trigran Investments, Inc.
- Anika Therapeutics Inc. shareholders
- Schedule 13G/A · Trigran Investments, Inc. · Jan 8, 2026
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Henneman John B III · Jun 23, 2026